483
Daiichi Sankyo Europe GmbHDaiichi Sankyo Europe GmbH – FDA 483, Jul 18, 2025
Record Details
This FDA Form 483 was issued to Daiichi Sankyo Europe GmbH, a drug product manufacturer in Pfaffenhofen A.D. Ilm, Germany, following an inspection from July 14-18, 2025. The inspection revealed significant deficiencies in laboratory record-keeping, inadequate investigations into deviations and out-of-specification results, and failures in equipment cleaning and maintenance procedures. These observations indicate a lack of robust quality control and data integrity practices.
View Company Profile
ID · 5f48dc36-8c0c-4493-a634-ec2288eadad6
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.